| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/16/1999 | US5872294 Phase transfer agents of hexasubstituted guanidium chlorides |
| 02/16/1999 | US5872131 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 02/16/1999 | US5872119 2-Naphthamide derivatives and their therapeutic applications |
| 02/16/1999 | US5872117 Treating cerebrovascular dementia, senile dementia, alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy |
| 02/16/1999 | US5872115 Compounds for treatment of hypercholesterolemia, ischemic heart disease, cerebrovascular disease or atherosclerosis |
| 02/11/1999 | WO1999006369A1 Neuraminidase inhibitors |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/10/1999 | EP0895989A1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity |
| 02/10/1999 | CN1207726A New mfg. process |
| 02/09/1999 | US5869655 Diamine compounds, methods of making same, method of use of same and intermediates |
| 02/09/1999 | US5869522 Solvent extraction; plant extracts; trimerization of 2,3-deoxy-1,4-naphthoquinone |
| 02/09/1999 | US5869501 Amidinonaphthyl derivative or salt thereof |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | CA2210023C Process for the preparation of paroxetine hydrochloride anhydrate form a. |
| 02/09/1999 | CA2163274C Intermediates for producing neuroleptic perhydro-1h-pyrido¬1,2-a| pyrazines |
| 02/04/1999 | WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | WO1999005133A1 Benzamide cycloalkyl stimulating high and low gastrointestinal motricity |
| 02/04/1999 | WO1999005108A1 Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
| 02/04/1999 | WO1999005106A1 Novel benzamide derivatives stimulating high and low gastrointestinal motricity |
| 02/04/1999 | WO1999004796A1 Fibrinogen receptor antagonists |
| 02/04/1999 | WO1999004794A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | WO1999004771A2 Use of levobupivacaine |
| 02/04/1999 | CA2297909A1 Fibrinogen receptor antagonists |
| 02/04/1999 | CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | CA2296314A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | CA2295631A1 Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
| 02/03/1999 | EP0894790A1 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetramethylpyridine |
| 02/03/1999 | EP0894088A1 Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
| 02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 02/03/1999 | CN1207096A 3-azetidinylalkylpiperidines or-pyrrolidines as tachykinin antagonists |
| 02/03/1999 | CN1041921C Bicyclic fibrinogen antagonists |
| 02/03/1999 | CN1041920C Glycerin derivative and its pharmacological use |
| 02/03/1999 | CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/03/1999 | CN1041918C Process for preparing acryl-piperidine carbiols |
| 02/02/1999 | US5866609 Substituted vinylurea derivatives and medicine containing the same |
| 02/02/1999 | US5866592 Fibrinogen receptor antagonist and pharmaceutical compositions comprising the same |
| 02/02/1999 | US5866577 Aromatic amidine derivatives and salts thereof |
| 01/28/1999 | WO1999003832A1 Piperidine oligomers and combinatorial libraries thereof |
| 01/28/1999 | WO1999003472A1 Peripherally acting anti-pruritic opiates |
| 01/28/1999 | WO1999003471A1 Improved delivery of multiple doses of medications |
| 01/28/1999 | WO1999003470A1 Medicinal product and method for treatment and prevention of cognitive disorders |
| 01/28/1999 | CA2296428A1 Piperidine oligomers and combinatorial libraries thereof |
| 01/28/1999 | CA2288833A1 Peripherally acting anti-pruritic opiates |
| 01/27/1999 | EP0893437A1 Tryptase inhibitor and novel guanidino derivatives |
| 01/27/1999 | EP0893118A1 Saturated alkylsubstituted N-mercaptoacetyl-heterocycles, agent and method for permanently shaping hair based thereon and processes for their preparation |
| 01/27/1999 | EP0892827A1 Stabilizer composition |
| 01/27/1999 | EP0892802A1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
| 01/27/1999 | EP0892783A1 Carboxylic acid derivatives with an aggregation-inhibiting action |
| 01/27/1999 | EP0669919B1 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 01/27/1999 | CN1206406A 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 01/26/1999 | US5863950 Amides or thio amide compounds with hydroxy or ether groups |
| 01/26/1999 | US5863923 Treatment of anxiety, psychosis, schizophrenia, drug abuse, irritable bowel syndrome |
| 01/26/1999 | US5863903 Antidiabetic agent |
| 01/21/1999 | WO1999002510A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | WO1999002498A1 Process and a novel intermediate for the preparation of flecainide |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | WO1999002494A1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 01/21/1999 | WO1999002163A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | WO1999002156A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates |
| 01/21/1999 | WO1999002146A1 Amino acid derivatives |
| 01/21/1999 | DE19727350C1 Verfahren zur Herstellung von Nifedipin A process for the preparation of nifedipine |
| 01/21/1999 | CA2295697A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2265671A1 Matrix metalloproteinase inhibitors |
| 01/20/1999 | EP0891962A1 Process for the preparation of fluorinated dicarbonyl compounds |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0707579B1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/19/1999 | US5861513 Preparation of 1-acetyl-4-piperidones |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861509 Neurokinin and tachykinin antagonists; respiratory system disorders, antiinflammatory agents |
| 01/19/1999 | US5861425 Indole-ethanamines |
| 01/19/1999 | US5861418 Aminobenzoic acid derivatives |
| 01/19/1999 | US5861407 Tetrahydropyridine derivatives as dopamine receptor subtype ligands |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/14/1999 | WO1999001456A1 Synthesis of and intermediates for camptothecins |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001432A1 Anti-diabetic agent |
| 01/14/1999 | WO1999001428A1 Hydrazine derivatives |
| 01/14/1999 | WO1999001427A2 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001127A1 Compounds and methods |
| 01/14/1999 | CA2295062A1 Hydrazine derivatives |
| 01/14/1999 | CA2294770A1 Compounds and methods |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2293501A1 Nitric oxide-releasing amidine-derived diazeniumdiolates, compositions and uses thereof |
| 01/13/1999 | EP0889918A1 In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 01/13/1999 | EP0889890A1 Nitroxyl containing compounds |
| 01/13/1999 | EP0889879A1 Butadiene derivatives and process for preparing thereof |
| 01/13/1999 | EP0889876A1 Meta-substituted phenylene sulphonamide derivatives |
| 01/13/1999 | EP0757670B1 Benzamide derivatives as vasopressin antagonists |
| 01/13/1999 | CN1205004A Esters of 3-hydroxy-piperidinemethanol derivatives |
| 01/12/1999 | US5859250 Preparation of 4-amino-2,2,6,6-tetramethylpiperidine (TAD) via 2,2,6,6-tetramethyl-4- (2,2,6,6-tetramethyl-4-piperidylidene) amino!piperidine as intermediate |
| 01/12/1999 | US5859249 2-phenyl-2-(2'-piperidinylidene)acetate derivative, process for manufacturing the same, and process for manufacturing optically active 2-phenyl-2-(2'-piperidinyl)acetate derivative by asymmetrically hydrogenating the same |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859239 Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines |